Lucia Bio Pty Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Lucia Bio Pty Ltd - overview
Established
2024
Location
-, -, Australia
Primary Industry
Biotechnology
About
Based in Queensland, Australia, and founded in 2024 by Tom McCarthy, Lucia Bio Pty Ltd operates as a a Molecule to Medicine (MTM) portfolio biotechnology company. In August 2025, Lucia Bio Pty Ltd raised USD 2 million in seed funding from Uniseed and UniQuest Limited. Lucia Bio develops next-generation selective spleen tyrosine kinase (Syk) inhibitors aimed at treating immune-mediated diseases. Lucia Bio engages in the development of its lead candidates—QED-701 and QED-121.
These molecules are designed to address neuroinflammatory disorders and peripheral autoimmune conditions by targeting Syk, a clinically validated node in human immunology. QED-701 is advancing through toxicology studies for neurodegenerative-related inflammation, while QED-121 is progressing through Chemistry, Manufacturing and Controls (CMC) activities to support clinical trial readiness for autoimmune indications. The company will use the funding to advance QED-701 and QED-121 toward clinical studies and expand their use from neuroinflammation to autoimmune diseases.
Current Investors
Uniseed, UniQuest Limited
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy
Website
www.lucia.bio
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.